Covered recipient · General Payments record
ERIN A MCKEOWN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2022
$450.83
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $210.94 | 9 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | $54.19 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $46.22 | 2 |
| Grifols USA, LLC | $37.55 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.42 | 1 |
| OptiNose US, Inc. | $19.03 | 1 |
| Acerta Pharma LLC | $15.43 | 1 |
| Blueprint Medicines Corporation | $14.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Aimmune Therapeutics, Inc. | $28.65 | 01/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 954231725 | CMS |
| Aimmune Therapeutics, Inc. | $25.54 | 03/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 954232433 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.43 | 02/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 914683823 | CMS |
| Blueprint Medicines Corporation | $14.10 | 02/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 958941035 | CMS |
| Grifols USA, LLC | $37.55 | 02/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918662461 | CMS |
| Novartis Pharmaceuticals Corporation | $22.63 | 02/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 894914401 | CMS |
| Novartis Pharmaceuticals Corporation | $23.59 | 03/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | 894914403 | CMS |
| OptiNose US, Inc. | $19.03 | 02/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 928125106 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.42 | 01/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 956093103 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022
- Source files
- Dataset page · Bulk file · PY2021 , PY2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.